Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Orecchini

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
RNA Biology|June 23, 2017
Restricting retrotransposons: ADAR1 is another guardian of the human genomeElisa Orecchini, Loredana Frassinelli, Alessandro Michienzi
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|February 4, 2018
Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminasesElisa Orecchini, Loredana Frassinelli, Silvia Galardi, et al.
Cancers|July 20, 2021
Epitranscriptomics: A New Layer of microRNA Regulation in CancerVeronica De Paolis, Elisa Lorefice, Elisa Orecchini, et al.
Virology|September 13, 2015
The ADAR1 editing enzyme is encapsidated into HIV-1 virionsElisa Orecchini, Maurizio Federico, Margherita Doria, et al.
Plos One|December 3, 2014
HIV-1 infection causes a down-regulation of genes involved in ribosome biogenesisClaudia L Kleinman, Margherita Doria, Elisa Orecchini, et al.
RNA Biology|April 11, 2014
The HIV-1 Tat protein modulates CD4 expression in human T cells through the induction of miR-222Elisa Orecchini, Margherita Doria, Alessandro Michienzi, et al.
RNA Biology|July 5, 2021
The RNA editing enzyme ADAR2 restricts L1 mobilityLoredana Frassinelli, Elisa Orecchini, Sofian Al-Wardat, et al.
Nucleic Acids Research|September 24, 2016
ADAR1 restricts LINE-1 retrotranspositionElisa Orecchini, Margherita Doria, Ambra Antonioni, et al.
Genes & Diseases|January 31, 2024
Characterization of the molecular dysfunctions occurring in Aicardi-Goutières syndrome patients with mutations in ADAR1Sofian Al Wardat, Loredana Frassinelli, Elisa Orecchini, et al.
Cancers|December 23, 2022
Characterization of Glioblastoma Cells Response to RegorafenibMaria Patrizia Mongiardi, Mariachiara Buccarelli, Alessia Formato, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
RNA Biology|June 23, 2017
Restricting retrotransposons: ADAR1 is another guardian of the human genomeElisa Orecchini, Loredana Frassinelli, Alessandro Michienzi
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|February 4, 2018
Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminasesElisa Orecchini, Loredana Frassinelli, Silvia Galardi, et al.
Cancers|July 20, 2021
Epitranscriptomics: A New Layer of microRNA Regulation in CancerVeronica De Paolis, Elisa Lorefice, Elisa Orecchini, et al.
Virology|September 13, 2015
The ADAR1 editing enzyme is encapsidated into HIV-1 virionsElisa Orecchini, Maurizio Federico, Margherita Doria, et al.
Plos One|December 3, 2014
HIV-1 infection causes a down-regulation of genes involved in ribosome biogenesisClaudia L Kleinman, Margherita Doria, Elisa Orecchini, et al.
RNA Biology|April 11, 2014
The HIV-1 Tat protein modulates CD4 expression in human T cells through the induction of miR-222Elisa Orecchini, Margherita Doria, Alessandro Michienzi, et al.
RNA Biology|July 5, 2021
The RNA editing enzyme ADAR2 restricts L1 mobilityLoredana Frassinelli, Elisa Orecchini, Sofian Al-Wardat, et al.
Nucleic Acids Research|September 24, 2016
ADAR1 restricts LINE-1 retrotranspositionElisa Orecchini, Margherita Doria, Ambra Antonioni, et al.
Genes & Diseases|January 31, 2024
Characterization of the molecular dysfunctions occurring in Aicardi-Goutières syndrome patients with mutations in ADAR1Sofian Al Wardat, Loredana Frassinelli, Elisa Orecchini, et al.
Cancers|December 23, 2022
Characterization of Glioblastoma Cells Response to RegorafenibMaria Patrizia Mongiardi, Mariachiara Buccarelli, Alessia Formato, et al.
Pageof 2